TERT and urinary bladder cancer: Indeed, in the Golestan cohort followed for up to 14 years, Hosen et al. identified the presence of TERT promoter mutations in urine samples of 47% asymptomatic individuals, who subsequently developed primary bladder cancer, and in none of matched controls who did not develop bladder cancer (Hosen et al., 2020).